<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02549105</url>
  </required_header>
  <id_info>
    <org_study_id>Ain Shams MH</org_study_id>
    <nct_id>NCT02549105</nct_id>
  </id_info>
  <brief_title>Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section</brief_title>
  <official_title>A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And Wound Infiltration With Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And wound Infiltration
      with Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare the effectiveness of topically applied
      lidocaine-prilocaine (EMLA) cream with local anesthetic (lidocaine) infiltration on
      post-cesarean section pain.

      Research Question:

      Is lidocaine-prilocaine (EMLA) cream application effective as compared to local anesthetic
      (lidocaine) infiltration on post-caesarean section pain?

      Research Hypothesis:

      Lidocaine-prilocaine (EMLA) cream application is effective in post_caesarean section pain as
      compared to local anesthetic (lidocaine) infiltration.

      Clinical Application :

      Topical Lidocaine-prilocaine (EMLA) cream could be applied frequent times postoperatively,
      unlike infiltration with local anesthetic.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TIME TO THE FIRST DOSE OF RESCUE ANALGESIC IN THE FIRST 6 HOURS</measure>
    <time_frame>6 H</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>POSTOPERATIVE PAIN ACCORDING TO VAS</measure>
    <time_frame>24 H</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>EMLA CREAM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EMLA CREAM 5 mg TOPICAL APPLICATION FOR CS WOUND AND ASSESSMENT FOR POST OPERATIVE PAIN IN FIRST 6 HOURS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LIDOCAINE INFILTERATION</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LIDOCAINE 1 % 20 ml INFILTERATION FOR WOUND AND ASSESSMENT OF POST OPERATIVE PAIN IN FIRST 6 HOURS</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EMLA CREAM 5 mg</intervention_name>
    <description>EMLA CREAM APPLICATION FOR WOUND AFTER CS</description>
    <arm_group_label>EMLA CREAM</arm_group_label>
    <other_name>EMLA CREAM, PRILOCAIN 25 LIDOCAIN 25</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LIDOCAINE 1 %</intervention_name>
    <description>LIDOCAINE 1 % INFILTERATION FOR WOUND AND ASSESSMENT OF PAIN IN FIRST 6 HOURS</description>
    <arm_group_label>LIDOCAINE INFILTERATION</arm_group_label>
    <other_name>XYLOCAINE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18 and 40 years.

          2. Patient American Society of Anesthesiologists physical status І or П.

          3. Gestational age of pregnancy of 37w or more.

          4. Patient have no previous section or have 1or 2 previous sections.

          5. Patient having no medical disorders.

          6. Patient with no obstetrical complications.

        Exclusion Criteria:

          1. age below18 or above 40.

          2. Women American Society of Anesthesiologists physical status ш or more.

          3. Women having more than 2 previous cesarean section.

          4. Women receive cardio vascular drugs or having history of cardio vascular disease.

          5. Women with Medical disorders with pregnancy as diabetes milletus.

          6. Women having obstetrical complications as antepartum hemorrhage, pre-eclampsia or
             eclampsia.

          7. Women having metabolic, hormonal, respiratory, renal and hepatic disease.

          8. Women with any severe allergic condition or severe asthma.

          9. Mental condition rendering the patients unable to understand the nature, scope and
             possible consequences of the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MAGED R ABO SAEDA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIN SHAMS MATERNAL HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>HANY A IBRAHIM, MBBCH</last_name>
    <phone>01220034468</phone>
    <email>DR.HANY_AYAD@YAHOO.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>AHMED M MAMDOUH, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ain Shams university Maternity hospital</name>
      <address>
        <city>Cairo</city>
        <state>Abbasya</state>
        <zip>11821</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maged R Aboseda, professor</last_name>
      <phone>00201069190707</phone>
      <email>ahmadhassan376@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2015</study_first_posted>
  <last_update_submitted>September 11, 2015</last_update_submitted>
  <last_update_submitted_qc>September 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>HANY AYAD IBRAHIM</investigator_full_name>
    <investigator_title>RESIDENT DOCTOR</investigator_title>
  </responsible_party>
  <keyword>EMLA CREAM</keyword>
  <keyword>LIDOCAINE INFILTERATION</keyword>
  <keyword>PAIN RELIEF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>EMLA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

